Guinea vs Kazakhstan: Share of people with HIV who receive antiretroviral therapy
Guinea
74.0%
in 2024
Kazakhstan
74.0%
in 2024
Guinea rank
66th
Kazakhstan rank
66th
Share of people with HIV who receive antiretroviral therapy over time
- Guinea
- Kazakhstan
How they compare
Guinea currently reports 74.0% against 74.0% in Kazakhstan, a difference of 0.0%.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Kazakhstan ahead.
Guinea ranks 66th and Kazakhstan ranks 66th of 143 countries.
Across the 3 decades both report, Guinea averaged higher in 2 and Kazakhstan in 1.
Head to head by decade
| Decade | Guinea | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.9% | 2.2% | 1.7% | Guinea |
| 2010s | 28.4% | 25.7% | 2.7% | Guinea |
| 2020s | 60.8% | 65.0% | 4.2% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Guinea or Kazakhstan?
- Guinea, at 74.0% against 74.0% in Kazakhstan as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Guinea and Kazakhstan?
- 0.0%, with Guinea ahead.
- How many years of comparable data are there for Guinea and Kazakhstan?
- 25 years are reported by both, from 2000 to 2024.
- How do Guinea and Kazakhstan rank globally for share of people with hiv who receive antiretroviral therapy?
- Guinea ranks 66th and Kazakhstan ranks 66th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.